Similar articles

• Technology of production of primary and diploid cell cultures.

  Brackett RG. Brackett RG. Natl Cancer Inst Monogr. 1968 Dec;29:33-4. Natl Cancer Inst Monogr. 1968. PMID: 5720801 No abstract available.
• Tissue and medium antigens in vaccines.

  Coriell LL. Coriell LL. Natl Cancer Inst Monogr. 1968 Dec;29:179-91. Natl Cancer Inst Monogr. 1968. PMID: 4976862 Review. No abstract available.
• Clinical experience with vaccines produced in the human diploid cell line WI-38.

  Andzaparidze OG. Andzaparidze OG. Natl Cancer Inst Monogr. 1968 Dec;29:477-84. Natl Cancer Inst Monogr. 1968. PMID: 4976367 Clinical Trial. No abstract available.
• Identification standards of primary cultures and diploid cell lines--discussion.

  Stulberg CS. Stulberg CS. Natl Cancer Inst Monogr. 1968 Dec;29:15-9. Natl Cancer Inst Monogr. 1968. PMID: 5720789 No abstract available.
• Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.

  Yerganian G, Nell MA, Cho SS, Hayford AH, Ho T. Yerganian G, et al. Natl Cancer Inst Monogr. 1968 Dec;29:241-68. Natl Cancer Inst Monogr. 1968. PMID: 4306757 Review. No abstract available.